Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy

NCT05066607 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

NETWORK

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: Isatuximab

Sponsor

Intergroupe Francophone du Myelome

Collaborators

[object Object]
[object Object]